What is your policy for weaning polymyalgia rheumatica patients from corticosteroids after 2 years? How do you know when to stop the process, if at all?
Hazleman
B
B
Rheumatology Research Unit, Addenbrooke's Hospital, Cambridge.
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D011111:Polymyalgia Rheumatica / Q000188:drug therapy*; D012008:Recurrence; D012307:Risk Factors; D013997:Time Factors
D000305:Adrenal Cortex Hormones